Literature DB >> 1895382

Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

N Winter1, J C D'Halluin.   

Abstract

The IVa2 gene is located between 16 and 11.3 map units on the left strand of the adenovirus type 5 (Ad5) genome. The coded RNA contains an intron of 277 nucleotides. To determine whether protein IVa2 is synthetized during productive infection and to obtain an immunological reagent to study its function, we prepared antibodies directed to 414 amino acids of protein IVa2 fused to the N-terminal domain of Staphylococcus aureus protein A. Western immunoblot analysis of viral proteins demonstrates that protein IVa2 is a minor component of mature viral particles and that it is also present in assembly intermediates and young virions. Thus, contrary to a previous report (H. Persson, B. Mathisen, L. Philipson, and U. Pettersson, Virology 93:198-208, 1979), protein IVa2 is not related to the 50-kDa polypeptide, a scaffolding protein present in assembly intermediates. The biosynthesis of protein IVa2 during productive infection was examined. Time course studies using immunofluorescence analysis with polyclonal antibodies targeted to protein IVa2 revealed that this protein is first synthesized at 12 h in a few cells exhibiting very striking fluorescence. Synthesis continues until at least 24 h postinfection. When hydroxyurea is added, protein IVa2 is not detected. In cells infected with mutant H5 ts125, blocked at the nonpermissive temperature (40 degrees C) in viral DNA replication, protein IVa2 is overexpressed. These results suggest that protein IVa2 synthesis requires cellular rather than viral DNA replication. RNase protection assay results indicate that hydroxyurea inhibits protein IVa2 synthesis at the transcriptional level. Thus, overexpression of protein IVa2 in H5 ts125-infected cells may be regulated at the translational level.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1895382      PMCID: PMC249004     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

Review 1.  Viral proteins containing the purine NTP-binding sequence pattern.

Authors:  A E Gorbalenya; E V Koonin
Journal:  Nucleic Acids Res       Date:  1989-11-11       Impact factor: 16.971

2.  Isolation and characterization of monoclonal antibodies against the adenovirus core proteins.

Authors:  R Lunt; M E Vayda; M Young; S J Flint
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

3.  Adenovirus E1B proteins are required for accumulation of late viral mRNA and for effects on cellular mRNA translation and transport.

Authors:  L E Babiss; H S Ginsberg; J E Darnell
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

Review 4.  Regulation of adenovirus mRNA formation.

Authors:  S J Flint
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

5.  Role of the adenovirus 72-kDa DNA binding protein in the rapid decay of early viral mRNA.

Authors:  I Lazaridis; A Babich; J R Nevins
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

6.  Proximal and distal domains that control in vitro transcription of the adenovirus IVa2 gene.

Authors:  V Natarajan; M J Madden; N P Salzman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

7.  The upstream factor-binding site is not essential for activation of transcription from the adenovirus major late promoter.

Authors:  M Reach; L E Babiss; C S Young
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

8.  Hexon trimerization occurring in an assembly-defective, 100K temperature-sensitive mutant of adenovirus 2.

Authors:  N Morin; P Boulanger
Journal:  Virology       Date:  1986-07-15       Impact factor: 3.616

9.  Interaction of human adenovirus serotype 2 with human lymphoid cells.

Authors:  L Silver; C W Anderson
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

10.  Alternative internal splicing in c-myb RNAs occurs commonly in normal and tumor cells.

Authors:  G L Shen-Ong
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more
  17 in total

1.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Adenovirus late-phase infection is controlled by a novel L4 promoter.

Authors:  Susan J Morris; Gillian E Scott; Keith N Leppard
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Dependence of the encapsidation function of the adenovirus L1 52/55-kilodalton protein on its ability to bind the packaging sequence.

Authors:  Pilar Perez-Romero; Kurt E Gustin; Michael J Imperiale
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Adenovirus IVa2 protein binds ATP.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

5.  Nucleoplasmic and nucleolar distribution of the adenovirus IVa2 gene product.

Authors:  P Lutz; F Puvion-Dutilleul; Y Lutz; C Kedinger
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Properties of the adenovirus IVa2 gene product, an effector of late-phase-dependent activation of the major late promoter.

Authors:  P Lutz; C Kedinger
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

7.  The product of the adenovirus intermediate gene IVa2 is a transcriptional activator of the major late promoter.

Authors:  C Tribouley; P Lutz; A Staub; C Kedinger
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Comparison between E1A gene from oncogenic and non-oncogenic adenoviruses in cellular transformation (Ad E1A conserved region).

Authors:  V Leclére; I Huvent; P Verwaerde; C Cousin; J C D'Halluin
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

10.  Identification and characterization of a DNA binding domain on the adenovirus IVa2 protein.

Authors:  Joan B Christensen; Sean G Ewing; Michael J Imperiale
Journal:  Virology       Date:  2012-08-09       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.